Politicized public health agencies also make it harder to hold officials accountable ...
A growing Ebola outbreak in central Africa has reignited investor interest in antiviral biodefence plays, helping lift shares ...
Bundibugyo virus is an uncommon species of Ebola-causing virus that has been linked to only two other known outbreaks ...
Collaboration Leverages Prior Andes, Marburg and Ebola Virus Research and Dyadic’s C1 Platform Capabilities for Fast, ...
RICHMOND, Va., (WAVY) — Travelers returning to Virginia are facing airport restrictions if they have been visiting countries ...
A decade after Ebola vaccines changed outbreak response, a new epidemic in central Africa is caused by a strain the world ...
Collaboration Leverages Prior Andes, Marburg and Ebola Virus Research and Dyadic's C1 Platform Capabilities for Fast, Scalable Biologic ProductionJUPITER, Fla., May 28, 2026 (GLOBE NEWSWIRE) -- Dyadic ...
Each time an epidemic emerges, the same question surfaces regarding its origin. And with every zoonotic disease, the question ...
(NYSE American:NNVC, opens new tab) (the "Company"), a clinical stage leader developing antiviral drugs that viruses cannot ...
Twenty years ago, Joel Sartore embarked on an ambitious mission to photograph 25,000 species. On a recent visit to SC, he added a few more critters to the Photo Ark.
Hospitals say protocols developed after the 2014 Dallas cases have strengthened preparedness ahead of major international events.
NPR's Scott Detrow talks with virologist Dr. Thomas Geisbert about the vaccine used in the Ebola outbreak of 2014 and the challenges for developing a vaccine for this current health emergency.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results